Medicenna Therapeutics Corp.
(Toronto Stock Exchange : MDNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -1.06%570.512.7%$667.45m
ILMNIllumina, Inc. -0.79%317.923.5%$653.29m
AMGNAmgen, Inc. -1.46%227.731.3%$590.47m
ARRYArray BioPharma Inc. 3.18%39.7314.2%$518.21m
GILDGilead Sciences, Inc. -0.69%60.141.0%$503.58m
MRNAModerna, Inc. -2.48%69.550.0%$491.26m
VRTXVertex Pharmaceuticals, Inc. -2.43%209.341.9%$468.02m
IMMUImmunomedics, Inc. 0.09%87.8011.0%$388.12m
NVAXNovavax, Inc. -6.82%91.6596.5%$303.81m
ALXNAlexion Pharmaceuticals, Inc. -4.03%119.002.0%$285.72m
BIIBBiogen, Inc. -1.63%262.771.6%$253.41m
EXASEXACT Sciences Corp. -1.97%100.9920.7%$224.81m
BNTXBioNTech SE -8.28%86.540.0%$206.78m
SRNESorrento Therapeutics, Inc. -5.60%7.761.4%$181.81m
SGENSeagen Inc. 0.53%199.066.0%$170.98m

Company Profile

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.